Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mohammed I, Danjuma"'
Autor:
Mohammed I. Danjuma, Rana Sayed, Maryam Aboughalia, Aseel Hassona, Basant Selim Elsayed, Mohamed Elshafei, Abdelnaser Elzouki
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20155- (2023)
Background: Despite significant improvements in both treatment and prevention strategies, as well as multiple commissioned reviews, there remains uncertainty regarding the survival benefit of repurposed drugs such as colchicine in patients with Coron
Externí odkaz:
https://doaj.org/article/158651125d8240219898c01a72425e27
Autor:
Abdel-Naser Elzouki, MD, MSc, PhD, FRCP, FACP, Muhammad-Aamir Waheed, MD, FRCP, Salah Suwileh, MD, FRCP, Islam Elzouki, MD, Hisham Swehli, MD, Maryam Alhitmi, MD, Mona Saad, MD, Elmukhtar Habas, MD, PhD, FACHARZT, Suhail A. Doi, MD, PhD, Mohammed I. Danjuma, MD, MRCP
Publikováno v:
Surgery Open Science, Vol 7, Iss , Pp 46-51 (2022)
Background: Obesity is associated with increased prevalence of gastroesophageal reflux disease, with recent reports suggesting improvement in gastroesophageal reflux disease symptoms and weight loss following bariatric surgical intervention. However,
Externí odkaz:
https://doaj.org/article/7250be4cda8545a9a2e6bbeee3cf44cc
Autor:
Mohammed I. Danjuma, Oyelola A. Adegboye, Ahmed Aboughalia, Nada Soliman, Ruba Almishal, Haseeb Abdul, Mohamad Faisal Hamad Mohamed, Mohamed Nabil Elshafie, Abdulatif AlKhal, Abdelnaser Elzouki, Arwa Al-Saud, Mas Chaponda, Mubarak Arriyo Bidmos
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 13 (2022)
Background: There has been a rising prevalence of polypharmacy among people living with HIV (PLWH). Uncertainty however remains regarding the exact estimates of polypharmacy among these cohorts of patients. Methods: We conducted a systematic search o
Externí odkaz:
https://doaj.org/article/3a2b4b0e6126478eb207faa90c21a08d
Autor:
Fateen Ata, Zohaib Yousaf, Adeel Ahmad Khan, Almurtada Razok, Jaweria Akram, Elrazi Awadelkarim Hamid Ali, Ahmed Abdalhadi, Diaeldin Abdelgalil Ibrahim, Dabia Hamad S. H. Al Mohanadi, Mohammed I. Danjuma
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden of EuDKA in patien
Externí odkaz:
https://doaj.org/article/8c11be729c4a4190bbabeae68c63aca0
Autor:
Lina Mohammad Naseralallah, Bodoor Abdallah Aboujabal, Nejat Mohamed Geryo, Aisha Al Boinin, Fatima Al Hattab, Raza Akbar, Waseem Umer, Layla Abdul Jabbar, Mohammed I Danjuma
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0268705 (2022)
BackgroundDrug induced liver injury (DILI) is a rising morbidity amongst patients with COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated for use in the general population, but its utility for causality determinatio
Externí odkaz:
https://doaj.org/article/89384637f0724264a68fed955d0b4eba
Autor:
Mohammed A. Alamin, Mohammed Abdulgayoom, Sushil Niraula, Elabbass Abdelmahmuod, Ashraf O. Ahmed, Mohammed I. Danjuma
Publikováno v:
IDCases, Vol 26, Iss , Pp e01293- (2021)
Mucormycosis has multiple clinical phenotypes, which are more common in immunocompromised patients, especially those with diabetes mellitus. Debilitating rhino-orbital-cerebral and pulmonary infections by far represent the most typical clinical pheno
Externí odkaz:
https://doaj.org/article/b9cba6cf6d564bd88d555f99f63ad9f2
Autor:
Mahmood Mubasher, Tausif Syed, Amir Hanafi, Zhao Yu, Ibrahim Yusuf, Abdullah Sayied Abdullah, Mouhand FH Mohamed, Richard Alweis, Mohan Rao, Ryan Hoefen, Mohammed I Danjuma
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 14 (2020)
Background: Inflammatory bowel diseases (IBD) associated-chronic inflammation and autonomic dysregulation may predispose to arrhythmias. However, its exact prevalence is unknown. Thus, we aimed to ascertain the prevalence of arrhythmias in patients w
Externí odkaz:
https://doaj.org/article/2c6e7576e9324ed1b5e45ea35595d4c8
Publikováno v:
European Journal of Internal Medicine. 112:126-127
Autor:
Mohammed I Danjuma, soubiya ansari, Leen Maen Abu-Affifeh, Nawras Altikrity, Aisha Al-Sr, Unwam Jumbo, Lina Naseralallah
Background Despite its central role in drug metabolism, there is still residual uncertainty regarding the rising burden as well as exact definition of polypharmacy in patients with chronic liver disease. Methods We carried out a systematic search of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a236ad77726b8c670126b3e686d4a06d
https://doi.org/10.21203/rs.3.rs-1853050/v1
https://doi.org/10.21203/rs.3.rs-1853050/v1
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 280:198-199